Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 2/2008

01.12.2008 | Online Report

l-2-Hydroxyglutaric aciduria: Clinical and molecular study in three Tunisian families. Identification of a new mutation and inter-familial phenotype variability

verfasst von: A. Larnaout, R. Amouri, M. Kefi, F. Hentati

Erschienen in: Journal of Inherited Metabolic Disease | Sonderheft 2/2008

Einloggen, um Zugang zu erhalten

Summary

We report clinical and molecular studies in three unrelated Tunisian families containing seven patients with L2HGA. Although the age of onset is similar in all these patients at nearly 6 years, they progressively developed peculiar clinical phenotypes different from family to family. The three patients of family 1 showed mental retardation, epilepsy, cerebellar ataxia and pyramidal and pseudobulbar syndromes. The two patients of family 2 showed mental retardation and parkinsonism especially extrapyramidal stiffness, dystonia and myoclonus. The two patients of family 3 showed an intermediate phenotype; they share some clinical signs of the patients of family 1 (epilepsy, pyramidal and extrapyramidal syndromes) and some clinical signs of the patients of family 2 (extrapyramidal stiffness and dystonia). Molecular study identified a novel homozygous c.185C > A, p.A62D mutation on the L2HGDH gene in families 1 and 3 and the already known homozygous c.241A > G, p.K81E mutation in family 2. We suppose that the type of mutation in the L2HGDH gene does not play a complete role in the inter-familial phenotype variability. Disturbance of other unknown metabolic pathways related to L2HGA may contribute to this phenomenon.
Literatur
Zurück zum Zitat Ben-zeev B, Gross V, Kushnir T, et al (2001) Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol 16(2): 93–99.PubMed Ben-zeev B, Gross V, Kushnir T, et al (2001) Vacuolating megalencephalic leukoencephalopathy in 12 Israeli patients. J Child Neurol 16(2): 93–99.PubMed
Zurück zum Zitat de Klerk JB, Hujmans JG, Stroink H, et al (1997) l-2-Hydroxyglutaric aciduria (1997) Clinical heterogeneity versus biochemical homogeneity in a sibship. Neuropediatrics 28(6): 314–317. doi:10.1055/s-2007-973722.PubMedCrossRef de Klerk JB, Hujmans JG, Stroink H, et al (1997) l-2-Hydroxyglutaric aciduria (1997) Clinical heterogeneity versus biochemical homogeneity in a sibship. Neuropediatrics 28(6): 314–317. doi:10.​1055/​s-2007-973722.PubMedCrossRef
Zurück zum Zitat Lee C, Born M, Salomons GS, Jacobs C, Woelfle J (2006) Hemiconvulsion-hemiplegia-epilepsy syndrome as a presenting feature of l-2-hydroxyglutaric aciduria. J Child Neurol 21(6): 538–540.PubMed Lee C, Born M, Salomons GS, Jacobs C, Woelfle J (2006) Hemiconvulsion-hemiplegia-epilepsy syndrome as a presenting feature of l-2-hydroxyglutaric aciduria. J Child Neurol 21(6): 538–540.PubMed
Zurück zum Zitat Moroni I, Bugiani M, D’Incerti I, et al (2004) l-2-Hydroxyglutaric aciduria and brain malignant tumors, a predisposing condition. Neurology 62: 1882–1884.PubMed Moroni I, Bugiani M, D’Incerti I, et al (2004) l-2-Hydroxyglutaric aciduria and brain malignant tumors, a predisposing condition. Neurology 62: 1882–1884.PubMed
Zurück zum Zitat Ozişik PA, Akalan N, Palaoğlu S, Topçu M (2002) Medulloblastoma in a child with the metabolic disease l-2-hydroxyglutaric aciduria. Pediatr Neurosurg 37(1): 22–26. doi:10.1159/000065097.PubMedCrossRef Ozişik PA, Akalan N, Palaoğlu S, Topçu M (2002) Medulloblastoma in a child with the metabolic disease l-2-hydroxyglutaric aciduria. Pediatr Neurosurg 37(1): 22–26. doi:10.​1159/​000065097.PubMedCrossRef
Zurück zum Zitat Rzem R, Veiga-da-Cunha M, Noel G, et al (2004) A gene encoding a putative FAD-dependant l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101(48): 16849–16854. doi:10.1073/pnas.0404840101.PubMedCrossRef Rzem R, Veiga-da-Cunha M, Noel G, et al (2004) A gene encoding a putative FAD-dependant l-2-hydroxyglutarate dehydrogenase is mutated in l-2-hydroxyglutaric aciduria. Proc Natl Acad Sci U S A 101(48): 16849–16854. doi:10.​1073/​pnas.​0404840101.PubMedCrossRef
Zurück zum Zitat Sass JO, Jobard F, Topçu M, et al (2008) l-2-Hydroxyglutaric aciduria: identification of ten novel mutations in the L2HGDH gene. J Inherit Metab Dis. doi:10.1007/s10545-008-0855-4. Sass JO, Jobard F, Topçu M, et al (2008) l-2-Hydroxyglutaric aciduria: identification of ten novel mutations in the L2HGDH gene. J Inherit Metab Dis. doi:10.​1007/​s10545-008-0855-4.
Zurück zum Zitat Shafeghati Y, Vakili G, Entezari A (2006) l-2-Hydroxyglutaric aciduria: a report of six cases and review of the literature. Arch Iran Med 9(2): 165–169.PubMed Shafeghati Y, Vakili G, Entezari A (2006) l-2-Hydroxyglutaric aciduria: a report of six cases and review of the literature. Arch Iran Med 9(2): 165–169.PubMed
Zurück zum Zitat Topcu M, Jouhard F, Halliaz S, et al (2004) l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22): 2803–2811.PubMedCrossRef Topcu M, Jouhard F, Halliaz S, et al (2004) l-2-Hydroxyglutaric aciduria: identification of a mutant gene C14orf160, localized on chromosome 14q22.1. Hum Mol Genet 13(22): 2803–2811.PubMedCrossRef
Zurück zum Zitat Yilmaz K (2008) Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2008 Mar 14 [Epub ahead of print]. Yilmaz K (2008) Riboflavin treatment in a case with l-2-hydroxyglutaric aciduria. Eur J Paediatr Neurol 2008 Mar 14 [Epub ahead of print].
Metadaten
Titel
l-2-Hydroxyglutaric aciduria: Clinical and molecular study in three Tunisian families. Identification of a new mutation and inter-familial phenotype variability
verfasst von
A. Larnaout
R. Amouri
M. Kefi
F. Hentati
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe Sonderheft 2/2008
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-008-0934-6

Weitere Artikel der Sonderheft 2/2008

Journal of Inherited Metabolic Disease 2/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.